Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2+ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831

PURPOSE: This study investigated the association between tumor MYC protein expression and disease-free survival (DFS) of patients randomized to receive chemotherapy alone (Arm A) or chemotherapy with sequential (Arm B) or concurrent trastuzumab (Arm C) in the N9831 (Alliance) adjuvant HER2+ trastuzu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dueck, Amylou C., Reinholz, Monica M., Geiger, Xochiquetzal J., Tenner, Kathleen, Ballman, Karla, Jenkins, Robert B., Riehle, Darren, Chen, Beiyun, McCullough, Ann E., Davidson, Nancy E., Martino, Silvana, Sledge, George W., Kaufman, Peter A., Kutteh, Leila A., Gralow, Julie, Harris, Lyndsay N., Ingle, James N., Lingle, Wilma L., Perez, Edith A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3805021/
https://ncbi.nlm.nih.gov/pubmed/23965903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0558
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados